GynecologyGynecology2079-56962079-5831Consilium Medicum27627Research ArticleEtiologicheskaya rol' virusa papillomy cheloveka v razvitii raka sheyki matki: geneticheskie i patogeneticheskie mekhanizmy, vozmozhnosti terapii i profilaktikiKiselevV I-AshrafyanL A-BudarinaS O-KiselevO I-Pal'tsevM A-KulakovV I-PrilepskayaV N-150820046417418009042020Copyright © 2004, Consilium Medicum2004вирус папилломы человекарак шейки матки[Киселев В.И., Киселев О.И. Вирусы папилломы человека в развитии рака шейки матки. Спб.–М.: Роза мира, 2003.][Mc Cance D.J. Human papillomavirus (HPV) infection in the aetiology of cervical cancer. Cancer Sury 19884 7: 499–506.][Bedell M.A, Jones K.H, Laimins L.A. The E6-E7 region of hu man papillomavirus type 18 is sufficient for transformation of NIH 3T3 and rat-1 cells. J Virol 1987; 61: 3635–40.][Reeves W.G, Rawls W.E, Brinton L.A. Epidemiology of genital papillomavirus and cervical cancer. Rev Infect Dis 1989; 11: 426–39.][Phelps W.C, Barnes J.A and Loba D.C. Human papillomavirus: molecular targets and prospects for antiviral therapy. Internat Antiviral News 1999; 7: 4–8.][Young-Sik Cho, Jeong-Woo Kang, Min Chul Cho et al. Down modulation of EL-18 expession by human papillomavirus type 16 E6 oncogene via binding to IL-18. FEBS Letters 2001; 501: 139–45.][Cram E.J, Liu B.D, Bjeldanes L.F, Firestone G.L. Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Spl transcription factor interactions with a composite element in the CDK6 gene promoter, J Biol Chem 2001 Apr 10 [epub ahead of print].][Lawrence J.A, Malpas P.B, Sigman C.C, Kelloff G.J. Clinical development of estrogen modulators for breast cancer chemoprevention in premenopausal vs. postmenopausal women. J Cell Biochem 2000; 34 (Suppl.): 103–14.][Meng Q, Goldberg I.D, Rosen E.M, Fan S. Inhibitory effects of Indole-3-carbinol on invasion and migration in human breast cancer cells Breast Cancer Res Treat. 2000 Sep; 63 (2): 147–52.][Liang Jin, Mei Qi, Da-Zhi Chen et al. Indol-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV 16) transgenic mice. Cancer Research 1999; 59: 3991–7.][Yuan F, Chen D.Z, Liu К et al. Anti - estrogenic activities of indol-3-carbinol in cervical cells: implication for prevention of cervical cancer. Cancer Research 1999; 19 (3a): 1673–80.][Bell M.C, Crowley-Nowick R, Bradlow H.L et a. Placebo-Controlled Trail of indol-3-carbinol in the treatment of CIN (cervix cancer). Gynecologic Oncology 2000; 78: 123–9.]